New score shows improved prediction of mortality after acute kidney injury

NewsGuard 100/100 Score

Acute kidney injury (AKI) occurs commonly in critically ill patients admitted to the intensive care unit (ICU) and is associated with high morbidity and mortality.

Prediction of mortality and recovery after an episode of AKI may assist bedside decision-making. In a study recently published in the American Journal of Kidney Diseases, researchers described the development and validation of a clinical model using data from the first 3 days of an ICU stay to predict hospital mortality and major adverse kidney events occurring up to 120 days after hospital discharge among critically ill adult patients who developed AKI within the first 3 days of an ICU stay.

The proposed clinical models exhibited good performance for outcome prediction and, if further validated, could enable risk-stratification for timely interventions that promote kidney recovery.

Source:
Journal reference:

Neyra, J, A., et al. (2022) Prediction of Mortality and Major Adverse Kidney Events in Critically Ill Patients With Acute Kidney Injury. American Journal of Kidney Diseases. doi.org/10.1053/j.ajkd.2022.06.004

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Gene therapy and glycoside drugs offer new hope for polycystic kidney disease treatment